These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12401374)

  • 1. Phenotype of CYP2C19 and CYP3A4 by determination of omeprazole and its two main metabolites in plasma using liquid chromatography with liquid-liquid extraction.
    González HM; Romero EM; Chavez Tde J; Peregrina AA; Quezada V; Hoyo-Vadillo C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Nov; 780(2):459-65. PubMed ID: 12401374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitive determination of omeprazole and its two main metabolites in human plasma by column-switching high-performance liquid chromatography: application to pharmacokinetic study in relation to CYP2C19 genotypes.
    Shimizu M; Uno T; Niioka T; Yaui-Furukori N; Takahata T; Sugawara K; Tateishi T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Mar; 832(2):241-8. PubMed ID: 16497565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chiral assay of omeprazole and metabolites and its application to a pharmacokinetics related to CYP2C19 genotypes.
    Shiohira H; Yasui-Furukori N; Tateishi T; Uno T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Aug; 879(24):2465-70. PubMed ID: 21783435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of omeprazole sulfone in a single plasma sample as a probe for CYP3A4.
    Böttiger Y
    Eur J Clin Pharmacol; 2006 Aug; 62(8):621-5. PubMed ID: 16791583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP2C19- and CYP3A4-dependent omeprazole metabolism in West Mexicans.
    Gonzalez HM; Romero EM; Peregrina AA; de J Chávez T; Escobar-Islas E; Lozano F; Hoyo-Vadillo C
    J Clin Pharmacol; 2003 Nov; 43(11):1211-5. PubMed ID: 14551175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereospecific analysis of omeprazole in human plasma as a probe for CYP2C19 phenotype.
    Kanazawa H; Okada A; Higaki M; Yokota H; Mashige F; Nakahara K
    J Pharm Biomed Anal; 2003 Jan; 30(6):1817-24. PubMed ID: 12485723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. St John's wort induces both cytochrome P450 3A4-catalyzed sulfoxidation and 2C19-dependent hydroxylation of omeprazole.
    Wang LS; Zhou G; Zhu B; Wu J; Wang JG; Abd El-Aty AM; Li T; Liu J; Yang TL; Wang D; Zhong XY; Zhou HH
    Clin Pharmacol Ther; 2004 Mar; 75(3):191-7. PubMed ID: 15001970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of omeprazole and its metabolites in human plasma by liquid chromatography-mass spectrometry.
    Kanazawa H; Okada A; Matsushima Y; Yokota H; Okubo S; Mashige F; Nakahara K
    J Chromatogr A; 2002 Mar; 949(1-2):1-9. PubMed ID: 11999727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probing CYP2C19 and CYP3A4 activities in Chinese liver microsomes by quantification of 5-hydroxyomeprazole and omeprazole sulphone.
    Shu Y; Wang LS; Xiao WM; Wang W; Huang SL; Zhou HH
    Acta Pharmacol Sin; 2000 Aug; 21(8):753-8. PubMed ID: 11501187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Esomeprazole-induced healing of gastroesophageal reflux disease is unrelated to the genotype of CYP2C19: evidence from clinical and pharmacokinetic data.
    Schwab M; Klotz U; Hofmann U; Schaeffeler E; Leodolter A; Malfertheiner P; Treiber G
    Clin Pharmacol Ther; 2005 Dec; 78(6):627-34. PubMed ID: 16338278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of troleandomycin on the metabolism of omeprazole is CYP2C19 genotype-dependent.
    He N; Huang SL; Zhu RH; Tan ZR; Liu J; Zhu B; Zhou HH
    Xenobiotica; 2003 Feb; 33(2):211-21. PubMed ID: 12623762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonlinear kinetics after high-dose omeprazole caused by saturation of genetically variable CYP2C19.
    Rost KL; Roots I
    Hepatology; 1996 Jun; 23(6):1491-7. PubMed ID: 8675169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human CYP2C19 is a major omeprazole 5-hydroxylase, as demonstrated with recombinant cytochrome P450 enzymes.
    Karam WG; Goldstein JA; Lasker JM; Ghanayem BI
    Drug Metab Dispos; 1996 Oct; 24(10):1081-7. PubMed ID: 8894508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clopidogrel inhibits CYP2C19-dependent hydroxylation of omeprazole related to CYP2C19 genetic polymorphisms.
    Chen BL; Chen Y; Tu JH; Li YL; Zhang W; Li Q; Fan L; Tan ZR; Hu DL; Wang D; Wang LS; Ouyang DS; Zhou HH
    J Clin Pharmacol; 2009 May; 49(5):574-81. PubMed ID: 19398604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herbal medicine yin zhi huang induces CYP3A4-mediated sulfoxidation and CYP2C19-dependent hydroxylation of omeprazole.
    Fan L; Wang G; Wang LS; Chen Y; Zhang W; Huang YF; Huang RX; Hu DL; Wang D; Zhou HH
    Acta Pharmacol Sin; 2007 Oct; 28(10):1685-92. PubMed ID: 17883958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation of omeprazole sulphone but not 5-hydroxyomeprazole is inhibited by grapefruit juice.
    Tassaneeyakul W; Vannaprasaht S; Yamazoe Y
    Br J Clin Pharmacol; 2000 Feb; 49(2):139-44. PubMed ID: 10671908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of omeprazole, midazolam and hydroxy-metabolites in plasma using liquid chromatography coupled to tandem mass spectrometry.
    Frerichs VA; Zaranek C; Haas CE
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 824(1-2):71-80. PubMed ID: 16027049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interphenotype differences in disposition and effect on gastrin levels of omeprazole--suitability of omeprazole as a probe for CYP2C19.
    Chang M; Tybring G; Dahl ML; Götharson E; Sagar M; Seensalu R; Bertilsson L
    Br J Clin Pharmacol; 1995 May; 39(5):511-8. PubMed ID: 7669487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artemisinin induces omeprazole metabolism in human beings.
    Svensson US; Ashton M; Trinh NH; Bertilsson L; Dinh XH; Nguyen VH; Nguyen TN; Nguyen DS; Lykkesfeldt J; Le DC
    Clin Pharmacol Ther; 1998 Aug; 64(2):160-7. PubMed ID: 9728896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail".
    Streetman DS; Bleakley JF; Kim JS; Nafziger AN; Leeder JS; Gaedigk A; Gotschall R; Kearns GL; Bertino JS
    Clin Pharmacol Ther; 2000 Oct; 68(4):375-83. PubMed ID: 11061577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.